Page last updated: 2024-10-26

erythrosine and Multiple Sclerosis, Relapsing-Remitting

erythrosine has been researched along with Multiple Sclerosis, Relapsing-Remitting in 1 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
von Essen, MR1
Ammitzbøll, C1
Börnsen, L1
Sellebjerg, F1

Other Studies

1 other study available for erythrosine and Multiple Sclerosis, Relapsing-Remitting

ArticleYear
Assessment of commonly used methods to determine myelin-reactivity of T cells in multiple sclerosis.
    Clinical immunology (Orlando, Fla.), 2021, Volume: 230

    Topics: Adult; Autoantigens; Case-Control Studies; Enzyme-Linked Immunospot Assay; Female; Fluoresceins; Flu

2021